Inventor

KIM SUNG WUK

KR30 patents

⚠️ This page may combine multiple inventors who share the name “KIM SUNG WUK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KIM SUNG WUK

KIM SUNG WUK

Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient

N1-cyclic amine-N5-substituted phenyl biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same

Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient

N1-cyclic amine-N5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same

N1-2-thiophene-2-ylethyl-N2-substituted biguanide derivate, preparation method thereof, and pharmaceutical composition containing the same as active ingredients

N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same

N,N-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same

N1-benzo[1,3]dioxol-5-ylmethyl-N2-substituted biguanide derivative, preparation method thereof, and pharmaceutical composition containing same

Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor

Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same

Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing same

N,N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same

Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same

Controlled release complex composition comprising angiotensin-II-receptor blockers and HMG-CoA reductase inhibitors

IMMUNOMET THERAPEUTICS INC

Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient

Guanidine compounds and use thereof

Biguanide compound and use thereof

Pharmaceutical composition comprising a biguanide derivative as an active ingredient for preventing or treating glioblastoma

Pharmaceutical composition comprising N1-cyclic amine-N5-substituted biguanide derivatives as an ingredient for preventing or treating fibrosis

Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient

Biguanide compound and use thereof

Guanidine compounds and use thereof

Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient

HANALL BIOPHARMA CO LTD

Antibody binding to FcRn for treating autoimmune diseases

Antibody binding to FCRN for treating autoimmune diseases

Antibody binding to FcRn for treating autoimmune diseases

Uses of modified human tumor necrosis factor receptor-1 polypeptide

FcRn-specific human antibody and composition for treatment of autoimmune diseases

KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY

Composition for promoting hair growth comprising a guanine derivative

CHEON HYAE GYEONG

1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same